Results 331 to 340 of about 1,311,115 (388)

Efficacy and Safety of Bendamustine‐Rituximab for Nodular Lymphocyte Predominant Hodgkin Lymphoma

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Introduction Bendamustine‐rituximab (BR) has demonstrated efficacy and tolerability in the treatment of various indolent B‐cell lymphomas, but there is limited data regarding its outcomes in nodular lymphocyte predominant B‐cell (Hodgkin) lymphoma (NLPBL).
Alexander Robin   +6 more
wiley   +1 more source

Analysis of viral pneumonia and risk factors associated with severity of influenza virus infection in hospitalized patients from 2012 to 2016. [PDF]

open access: yesBMC Infect Dis
Fullana Barceló MI   +7 more
europepmc   +1 more source

Vaccination in Multiple Myeloma: Challenges and Strategies

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Background Multiple myeloma (MM) is a hematological malignancy characterized by profound immunosuppression resulting from both disease‐related mechanisms and treatment‐induced immune dysfunction. This compromised immune status markedly increases susceptibility to infections, a leading cause of morbidity and mortality in MM patients.
Enrica Antonia Martino   +10 more
wiley   +1 more source

Alveolar macrophage-expressed Plet1 is a driver of lung epithelial repair after viral pneumonia. [PDF]

open access: yesNat Commun
Pervizaj-Oruqaj L   +17 more
europepmc   +1 more source

Primary cutaneous CD8‐positive aggressive epidermotropic cytotoxic T‐cell lymphoma initially demonstrating near‐complete metabolic response to BV‐CHEP

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Tristen Tze Wei Ng   +5 more
wiley   +1 more source

Atypical infections during combination therapy with anifrolumab and other immunosuppressives in patients with lupus erythematosus: A case series

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Shae Chambers   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy